Skip to content

Tool for Inappropriate Prescription Evaluation: The TaIPE Study

Tool for Inappropriate Prescription Evaluation: The TaIPE Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04028583
Acronym
TaIPE
Enrollment
464
Registered
2019-07-22
Start date
2018-02-26
Completion date
2019-08-04
Last updated
2019-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inappropriate Prescribing

Keywords

Inappropriate Prescribing, Potentially Inappropriate Medication List, Aged, Practice Guideline, Education, Medical

Brief summary

A mono-center, randomized controlled trial will be conducted at the University Hospital of Lausanne. Hospitalized patients will be randomly assigned from the emergency department to two sub-units composing the acute care for elders (ACE) unit. In one subunit, potentially inappropriate prescriptions will be detected and treatment optimized according PIM-Check. In the other, STOPP/START criteria will be independently applied.

Interventions

OTHERPIM-Check

In the PIM-Check group, a medication review will be conducted using PIM-Check within 72 hours of patient's admittance to the unit. The physician will decide whether to accept these recommendations or not and implement prescribing changes if agreed.

OTHERSTOPP/START

In the STOPP/START group, medication lists will be analyzed within 72 hours of patient's admittance and optimized according to STOPP/START criteria. The second physician will decide whether to accept these recommendations or not and implement prescribing changes if agreed.

Sponsors

Centre Hospitalier Universitaire Vaudois
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All patients meeting the admission criteria of the acute care for elders (ACE) unit will be eligible.

Exclusion criteria

* none

Design outcomes

Primary

MeasureTime frame
Rate of Potentially Inappropriate Prescriptions (PIPs) reduction in the PIM-Check group compared to STOPP/START18 months

Secondary

MeasureTime frameDescription
Rate of acceptability18 months
Number of treatment (mean and median) modification by clinicians18 months
Number of drugs at discharge18 months
Incidence rate of falls18 months
Number and type of PIPs detected by each tool18 months
Confusion Assessment Method (CAM)18 monthsResult ranges : \[negative result (-) = no confusion\] ; \[positive result (+) = confusion\].
Length of stay18 months
Number of unplanned readmissionup to 3 months after discharge
Association between the number and type of PIPs at discharge with rate of re-admissionup to 3 months after discharge
Activities of daily living (ADL) score18 monthsActivities of daily living are routine activities people do every day without assistance (6 basic activities) : eating, bathing, getting dressed, toileting, transferring, and continence. The score is the number of activities performed without assistance. Score ranges : from 0/6 (minimum) to 6/6 (maximum). Higher values represent a better outcome of activities of daily living.

Countries

Switzerland

Contacts

Primary ContactChantal Csajka, PharmD, PhD
chantal.csajka@chuv.ch+41 21 314 42 63
Backup ContactAkram FARHAT, PharmD, MPH, PhD
akram.farhat@hotmail.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 13, 2026